What is apixaban? Apixaban is used to lower the risk of stroke caused by a blood clot in people with a heart rhythm disorder called atrial fibrillation. Apixaban is also used after hip or knee replacement surgery to prevent a type of blood clot called deep vein thrombosis (DVT), which can lead to blood clots in the lungs (pulmonary embolism).

Jul 29, 2006 · Apixaban is used to treat or prevent deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs. These blood clots can travel to the lungs and can become lodged in the blood vessels of the lungs, causing a …

Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa. [9][10][11] It is used as an alternative to warfarin to prevent blood clots following hip or knee replacement and in those ...

Jul 21, 2024 · Eliquis (apixaban) is commonly used for the following conditions. To prevent strokes and blood clots in people who have atrial fibrillation. People who have atrial fibrillation have an abnormal...

Feb 22, 2024 · Apixaban is a novel oral anticoagulant approved by the US Food and Drug Administration (FDA) in 2012 for use in patients with nonvalvular atrial fibrillation to reduce the risk of stroke and blood clots.

Apr 14, 2021 · Apixaban oral tablet is a prescription drug used to treat and prevent blood clots such as deep vein thrombosis (DVT) and pulmonary embolism (PE). It also helps decrease risk of stroke in atrial...

The anticoagulant Eliquis® (apixaban) inhibits factor Xa to prevent and treat blood clots and prevent stroke in people with atrial fibrillation but no valve issues.

Apixaban is used to help prevent strokes or blood clots in people who have atrial fibrillation (a condition in which the heart beats irregularly, increasing the chance of clots forming in the body and possibly causing strokes) that is not caused by heart valve disease.

Indicated for treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) 10 mg PO BID x 7 days, then 5 mg BID. Switching between apixaban and anticoagulants other than...

Mar 29, 2025 · In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and dec...